Cholesterol-Lowering Therapy

<p>Reveals important new results from clinical trials conducted in Scandinavia Scotland Australia Canada and the United States.<br>This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies presented in Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence promote cholesterol reduction as a highly successful means of preventing heart disease in various populations.<br>Investigates past current and upcoming controlled clinical trials of cholesterol-reduction therapies comparing effects of statins and bile acid sequestrants to triglyceride-lowering drugs and antioxidants.<br>Written by more than 25 distinguished international researchers Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence </p><li>highlights historical studies of dietary trials designed to reduce CHD <br> </li><li>covers tests of HMG CoA reductase inhibitors for patients with and without CHD <br> </li><li>illuminates CHD risk factors such as diabetes hypertension obesity and smoking <br> </li><li>explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors <br> </li><li>reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol <br> </li><li>and more!<br>Containing over 700 instructive tables drawings photographs and bibliographic citations Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists pharmacologists and upper-level undergraduate graduate and medical school students in these disciplines.</li>